Evidence map›Paper›PMID 26787826›Full record

ArticlemBio2016

Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences.

Macdonald Mahiti, Mako Toyoda, Xiaofei Jia, Xiaomei T Kuang, Francis Mwimanzi, Philip Mwimanzi, Bruce D Walker, Yong Xiong, Zabrina L Brumme, Mark A Brockman and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Modelling andVirus evolution · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Macdonald MahitiCenter for AIDS Research, Kumamoto University, Kumamoto, Japan International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
Mako ToyodaCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Xiaofei JiaDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Xiaomei T KuangSimon Fraser University, Burnaby, British Columbia, Canada.
Francis MwimanziCenter for AIDS Research, Kumamoto University, Kumamoto, Japan.
Philip MwimanziCenter for AIDS Research, Kumamoto University, Kumamoto, Japan Simon Fraser University, Burnaby, British Columbia, Canada.
Bruce D WalkerRagon Institute of MGH, MIT and Harvard University, Boston, Massachusetts, USA Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
Yong XiongDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Zabrina L BrummeSimon Fraser University, Burnaby, British Columbia, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Mark A BrockmanSimon Fraser University, Burnaby, British Columbia, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Takamasa UenoCenter for AIDS Research, Kumamoto University, Kumamoto, Japan International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan uenotaka@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0003-4852-4236
Kumamoto University · JPSimon Fraser University · CAYale University · USHoward Hughes Medical Institute · US

Funding

Viral Hijacking of Host Membrane Trafficking PathwaysR01AI102778 · NIAID · YALE UNIVERSITY · PI GUATELLI, JOHN C., XIONG, YONG · 2013 to 2017
$3.0M
Canadian Institutes of Health ResearchNIAID NIH HHS AI102778NIAID NIH HHS R01 AI102778
6 · The paper itself

Abstract

unlabelledHIV-1 Nef binds to the cytoplasmic region of HLA-A and HLA-B and downregulates these molecules from the surface of virus-infected cells, thus evading immune detection by CD8(+) T cells. Polymorphic residues within the HLA cytoplasmic region may affect Nef's downregulation activity. However, the effects of HLA polymorphisms on recognition by primary Nef isolates remain elusive, as do the specific Nef regions responsible for downregulation of HLA-A versus HLA-B. Here, we examined 46 Nef clones isolated from chronically HIV-1 subtype B-infected subjects for their ability to downregulate various HLA-A, HLA-B, and HLA-C molecules on the surface of virus-infected cells. Overall, HLA-B exhibited greater resistance to Nef-mediated downregulation than HLA-A, regardless of the cell type examined. As expected, no Nef clone downregulated HLA-C. Importantly, the differential abilities of patient-derived Nef clones to downregulate HLA-A and HLA-B correlated inversely with the sensitivities of HIV-infected target cells to recognition by effector cells expressing an HIV-1 Gag-specific T cell receptor. Nef codon function analysis implicated amino acid variation at position 202 (Nef-202) in differentially affecting the ability to downregulate HLA-A and HLA-B, an observation that was subsequently confirmed by experiments using Nef mutants constructed by site-directed mutagenesis. The in silico and mutagenesis analyses further suggested that Nef-202 may interact with the C-terminal Cys-Lys-Val residues of HLA-A, which are absent in HLA-B. Taken together, the results show that natural polymorphisms within Nef modulate its interaction with natural polymorphisms in the HLA cytoplasmic tails, thereby affecting the efficiency of HLA downregulation and consequent recognition by HIV-specific T cells. These results thus extend our understanding of this complex pathway of retroviral immune evasion. IMPORTANCE: Recognition of genetically diverse pathogens by the adaptive immune system represents a primary strategy for host defense; however, pathogens such as HIV-1 can evade these responses to achieve persistent infection. The HIV-1 nef gene and the HLA class I locus rank among the most diverse genes of virus and host, respectively. The HIV-1 Nef protein interacts with the cytoplasmic region of HLA-A and HLA-B and downregulates these molecules to evade cellular immunity. By combining molecular, genetic, and in silico analyses, we demonstrate that patient-derived Nef clones downregulate HLA-A more effectively than HLA-B molecules. This in turn modulates the ability of HIV-specific T cells to recognize HIV-infected cells. We also identify a naturally polymorphic site at Nef codon 202 and HLA cytoplasmic motifs (GG314,315 and CKV339-341) that contribute to differential HLA downregulation by Nef. Our results highlight new interactions between HIV-1 and the human immune system that may contribute to pathogenesis.

Indexed as

Down-RegulationHost-Pathogen InteractionsCell LineGenetic VariationHIV-1HLA-A AntigensHLA-B AntigensHLA-C AntigensHumansMutagenesis, Site-Directednef Gene Products, Human Immunodeficiency VirusHLA-A AntigensHLA-B AntigensHLA-C Antigensnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1

Identifiers

PMID26787826
PMCPMC4724998
OpenAlexW2273220476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.